Pfizer is considering selling its hospital drugs unit to divest non-core assets, following pressure from activist investor Starboard Value. The unit, Pfizer Hospital, focuses on antibiotics and sterile infusions, with Goldman Sachs exploring potential buyers.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing